SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-025116
Filing Date
2021-05-07
Accepted
2021-05-07 16:01:45
Documents
4
Period of Report
2021-05-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea140523-8k_inmunebioinc.htm 8-K 16458
2 SCRIPT FOR EARNINGS CALL HELD ON MAY 6, 2021 ea140523ex99-1_inmunebioinc.htm EX-99.1 130297
3 GRAPHIC ex99-1_001.jpg GRAPHIC 86469
4 GRAPHIC ex99-1_002.jpg GRAPHIC 17042
  Complete submission text file 0001213900-21-025116.txt   290703
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 21902480
SIC: 2836 Biological Products, (No Diagnostic Substances)